Connect with us

Technology

Biologit Boosts Patient Safety with World-First Automated Local Literature Monitoring Solution for Non-Indexed Sources

Published

on

* Biologit for Local Literature™ delivers results 15 x faster than traditional searches, and is considerably more accurate and reliable. * The new managed service, already live at a top 10 pharma company, harnesses a technology ingestion model built by Biologit to fill a critical gap in pharmacovigilance, at scale. *Local literature surveillance is a highly resource-intensive mandatory activity, with significant budget implications yet with relative low yield for safety events.

DUBLIN, April 2, 2025 /PRNewswire-PRWeb/ — Biologit, a specialist in advanced, technology-enabled safety surveillance solutions for life sciences, has launched a world-first automation solution for local literature monitoring. Biologit for Local Literature™ solves the costly and complex problem of how to reliably identify adverse events and relevant safety information across the full spectrum of local literature sources, including non-indexed and hard-to-access country-specific publications.

This is a huge breakthrough for pharmacovigilance and patient safety. Truly comprehensive local literature screening has been a huge headache – and cost – for the pharma industry up to now.

The new managed data service, which is already live at a top 10 global biopharma company, fills a critical gap in current international safety surveillance. That’s because a significant proportion of adverse events first come to light via discrete local medical publications and online sources that are not picked up by routine open-source global literature searches. The activity’s critical importance is recognised by regulators, which mandate that pharma companies screen for safety events in all relevant markets.

The traditional screening process for local medical literature is inefficient and unreliable:

Highly manual and time-consuming, it requires dedicated staff at an affiliate or regional level;It yields only limited safety information. Errors and omissions are common;These issues are compounded by inconsistency in the format, indexing; access issues (e.g. paid subscriptions/print-only formats); language barriers; and variances in regulators’ reporting expectations.

Biologit for Local Literature uses advanced technology to overcome this challenge, efficiently, reliably and at scale. It has been shown to yield a 15-fold acceleration in safety event reporting when applied to a broad spectrum of local sources across 30 EU countries, with impressive accuracy.

Optimised algorithms, closely governed

Biologit for Local Literature uses a technology-based ingestion model developed by Biologit’s expert engineers. Each source is evaluated, and proprietary technology methods (including optimised algorithms that act as automated ‘crawlers’ per site) are used to support the ingest of any non-indexed in-country literature source as required. Even hard-to-reach print sources, conference proceedings and websites are included. As part of the managed service, Biologit’s operations team then confirms the findings manually, balancing process innovation with strong governance to contain any risk and ensure the product is audit-ready.

This innovative solution complements the company’s existing Biologit Database™, an extensive and continuously updated range of indexed, open-source global, regional and national medical publications and online resources. The ability to screen more diverse, non-standardised local sources in a reliable and highly efficient way – and filter searches by country – via Biologit’s new bespoke managed data service, rounds off the solution suite.

The combined 360-degree screening is powered by Biologit Platform™, Biologit’s powerful scientific literature monitoring platform, which features flexible workflow and unique AI productivity features. Biologit for Local Literature removes the final source of pain and risk from literature monitoring, raising the overall benefit to patient safety. ALL safety events are accessible via a single window, or query.

Delivered via the Biologit Platform, Biologit for Local Literature covers all countries and includes automated machine translation for hundreds of languages. The innovative technology allows for country-level data filtering for specific local searches, and individual country reporting and audit trails. It also supports single, integrated searches for global and local safety events.

Commenting on the significance of Biologit for Local Literature, Nicole Baker, Biologit’s CEO and co-founder, said:

“This is a huge breakthrough for pharmacovigilance and patient safety. Truly comprehensive local literature screening has been a huge headache – and cost – for the pharma industry up to now. Worse than that, it hasn’t delivered. This world-first, tech-enabled managed service ensures accurate and complete coverage for all journals, websites and subscription-based publications of interest in a country, delivered with unprecedented efficiency.

“Our use of automation allows us to do this at scale. This is not about assigning large service teams, or trying to track everything in spreadsheets. With Biologit for Local Literature we harness technology including specially-developed crawlers which are fast and reliable, and everything is properly overseen by our skilled people, to verify the accuracy and reliability of the output. Given the high sensitivity of patient safety, and the strict PV/Regulatory requirements, we have taken great pains to balance innovation and risk, and the results are exceeding all expectations.”

A new white paper, A World First: Integrated, Automated Global & Local Literature Monitoring for Pharmacovigilance is available for download on the Biologit website here. To arrange a 1:1 demonstration please email jean.redmond@biologit.com.

About Biologit

Biologit is an innovator in pharmacovigilance (PV), revolutionising the way that life science organisations handle literature review and monitoring, using cutting-edge automation technology wherever appropriate. Founded with a mission to enhance patient safety and operational efficiency, Biologit empowers pharmaceutical, biotech and PV service providers to simplify and streamline their processes. At the heart of Biologit’s Platform is its AI-powered literature automation tool, designed to transform manual and time-intensive tasks into seamless, efficient workflows. Biologit adheres to the highest industry standards, including ISO 27001 certification, GxP compliance, and alignment with FDA regulations.

PR Contact

Carina Birt, Sarum Life Sciences

carina@sarumlifesciences.com

+44 7970 006624

Media Contact

Jean Redmond, biologit, 44 00000000000, jean.redmond@biologit.com, https://www.biologit.com/

View original content:https://www.prweb.com/releases/biologit-boosts-patient-safety-with-world-first-automated-local-literature-monitoring-solution-for-non-indexed-sources-302417543.html

SOURCE biologit

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

HUYA Inc. to Report Second Quarter 2026 Financial Results on Tuesday, August 11, 2026

Published

on

By

-Earnings Webinar Scheduled for 6:00 a.m. ET on August 11, 2026-

GUANGZHOU, China, July 21, 2026 /PRNewswire/ — HUYA Inc. (“Huya” or the “Company”) (NYSE: HUYA), a leading game-related entertainment and services provider, today announced that it will report its second quarter 2026 unaudited financial results on Tuesday, August 11, 2026, before the open of U.S. markets.

The Company’s management will host a Tencent Meeting Webinar at 6:00 a.m. U.S. Eastern Time on August 11, 2026 (6:00 p.m. Beijing/Hong Kong time on August 11, 2026), to review and discuss the Company’s business and financial performance.

For participants who wish to join the webinar, please complete the online registration in advance using the links provided below. Upon registration, participants will receive an email with webinar access information, including meeting ID, meeting link, dial-in numbers, and a unique attendee ID to join the webinar.

Participant Online Registration

A live webcast of the webinar will be accessible at https://ir.huya.com, and a replay of the webcast will be available following the session.

[1] For the purpose of this announcement only, Chinese Mainland excludes the Hong Kong Special Administrative Region, the Macao Special Administrative Region of the People’s Republic of China, and Taiwan.

About HUYA Inc.

HUYA Inc. is a leading game-related entertainment and services provider. Huya delivers dynamic live streaming and video content and a rich array of services spanning games, e-sports, and other interactive entertainment genres to a large, highly engaged community of game enthusiasts. Huya has cultivated a robust entertainment ecosystem powered by AI and other advanced technologies, serving users and partners across the gaming universe, including game companies, e-sports tournament organizers, broadcasters and talent agencies. Leveraging this strong foundation, Huya has also expanded into innovative game-related services, such as game distribution, in-game item sales, advertising and more. Huya continues to extend its footprint in China and abroad, meeting the evolving needs of gamers, content creators, and industry partners worldwide.

For more information, please visit: https://ir.huya.com.

For investor and media inquiries, please contact:

In China:

HUYA Inc.
Investor Relations
Tel: +86-20-2290-7829
E-mail: ir@huya.com

Piacente Financial Communications
Jenny Cai
Tel: +86-10-6508-0677
E-mail: huya@tpg-ir.com

In the United States:

Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
E-mail: huya@tpg-ir.com

View original content:https://www.prnewswire.com/news-releases/huya-inc-to-report-second-quarter-2026-financial-results-on-tuesday-august-11-2026-302830290.html

SOURCE HUYA Inc.

Continue Reading

Technology

Hyperscale Data Bitcoin Treasury Reaches 1,087 Bitcoin Worth Approximately $70.3 Million

Published

on

By

LAS VEGAS, July 21, 2026 /PRNewswire/ — Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence (“AI”) data center company anchored by Bitcoin (“Hyperscale Data” or the “Company”), today announced that, as of July 19, 2026, it held 1,087.4527 Bitcoin representing an aggregate value of approximately $70.3 million based on the Bitcoin closing price of $64,691 on July 19, 2026.

In aggregate, the Company’s wholly owned subsidiaries, Sentinum, Inc. (“Sentinum”) and Ault Capital Group, Inc. (“ACG”), held 1,087.4527 Bitcoin as of July 19, 2026. During the week ended July 19, 2026, ACG purchased approximately 51.5000 Bitcoin in the open market. Based on the Bitcoin closing price of $64,691 on July 19, 2026, these collective holdings had an approximate market value of $70.3 million.

“We now hold more than $70 million in Bitcoin,” stated Milton “Todd” Ault III, Executive Chairman of Hyperscale Data. “The market remains completely disconnected from what we are building through our Michigan data center, our Bitcoin treasury, and our broader portfolio of operating businesses. Separate from the more than 1,087 Bitcoin we currently hold on our balance sheet, the market places zero value on the cash or the value of the other assets on our balance sheet. We will continue executing, growing our assets and highlighting the widening gap between the Company’s market capitalization and its underlying value.”

For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors and any other interested parties read Hyperscale Data’s public filings and press releases available under the Investor Relations section at hyperscaledata.com or available at www.sec.gov.

About Hyperscale Data, Inc.

Through its wholly owned subsidiary Sentinum, Hyperscale Data owns and operates a data center at which it mines digital assets and offers colocation and hosting services for the emerging AI ecosystems and other industries. Hyperscale Data’s other wholly owned subsidiary, ACG, is a hybrid private equity firm and operating company that acquires, finances, builds and actively manages businesses across financial services, digital assets, industrial services, hospitality, defense technologies and other sectors.

Hyperscale Data currently expects the divestiture of ACG (the “Divestiture”) to occur in the second quarter of 2027. Upon the occurrence of the Divestiture, the Company would be an owner and operator of data centers to support high-performance computing services, as well as a holder of the digital assets. Until the Divestiture occurs, the Company will continue to provide, through ACG and its wholly and majority-owned subsidiaries and strategic investments, mission-critical products that support a diverse range of industries, including an AI software platform, equipment rental services, defense/aerospace, industrial, automotive and hotel operations. In addition, ACG is actively engaged in private credit and structured finance through Ault Lending, LLC, a licensed lending subsidiary. Hyperscale Data’s headquarters are located at 11411 Southern Highlands Parkway, Suite 190, Las Vegas, NV 89141.

On December 23, 2024, the Company issued one million (1,000,000) shares of a newly designated Series F Exchangeable Preferred Stock (the “Series F Preferred Stock”) to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the “ACG Shares”). The Company reminds its stockholders that only those holders of the Series F Preferred Stock who agree to surrender such shares, and do not properly withdraw such surrender, in the exchange offer through which the Divestiture will occur, will be entitled to receive the ACG Shares and consequently be shareholders of ACG upon the occurrence of the Divestiture.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties.

Forward looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at hyperscaledata.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/hyperscale-data-bitcoin-treasury-reaches-1-087-bitcoin-worth-approximately-70-3-million-302830244.html

SOURCE Hyperscale Data Inc.

Continue Reading

Technology

ZELLERFELD GIVES FOOTWEAR ITS SPOTIFY MOMENT

Published

on

By

Music had Spotify. Video had YouTube. Zellerfeld has launched footwear’s biggest update, and the digitalization of footwear never felt so good.

AUSTIN, Texas, July 21, 2026
/PRNewswire/ — After years of bringing global brands and thousands of creators into its printed footwear revolution, Zellerfeld is rolling out its biggest platform update yet. The new Zellerfeld brings the marketplace, the product and the process into one beautifully connected experience, making printed footwear feel like it has finally caught up to the rest of the digital world. Browsing, discovering and experiencing printed shoes has never felt this good.

That experience is powered by personalized discovery, smarter search and live rankings for creators and products, rising with real demand instead of fading after a single launch moment. For the first time, footwear becomes digitally searchable, rankable and alive.

ZellerFIT is becoming the platform’s beating heart. The system lets users create a Fit Profile from a foot scan and personalisation choices. Once created, that Fit Profile can be carried across Zellerfeld products, creators and future shoes. Fit stops being a size guessed at checkout. It becomes personal, saved and portable, something that belongs to the user and moves with every shoe they print.

Powering the platform is Zellerfeld’s full-stack 3D-printed footwear infrastructure. Across Austin, Texas, and Hamburg, Germany, Zellerfeld now operates the largest and most advanced footwear creation facilities in the world, with thousands of printing units turning digital designs into physical shoes without moulds, stitching or assembly. At the push of a button, digital design, personal fit and physical production connect in one system.

“We always said we wanted to digitize footwear in the same way music and video were digitized, and the last years were spent building the fulfillment infrastructure to make that possible,” said Cornelius Schmitt, CEO and Co-Founder of Zellerfeld. “We never had time to give our users or creators the platform they deserved. Now we finally have. The new Zellerfeld looks so beautiful I can’t stop looking at it. I can’t wait to see what product category we digitize after footwear. Handbags? Glasses? I’m sure we’ll take one step at a time.”

The new platform also teases Zellerfeld subscription access. Major brands have tried to make footwear membership work, but most could only add perks on top of the same old retail model with limited designs. Zellerfeld makes footwear subscription work at scale: one platform, four pairs a year, a growing universe of designs, the same personal fit across every product and shoes printed on demand.

“Why would you go into a shoe store with 100 designs that all look the same and don’t really fit,” said Cornelius Schmitt, CEO and Co-Founder of Zellerfeld, “when you could come to Zellerfeld for millions of beautiful designs from creators around the world, all made to fit you?”

For the best part of a decade, Zellerfeld has been building the technology behind printed footwear, proving the category through breakthrough products and collaborators across sport, fashion, design and culture. Its work has shown that shoes can be digitally designed, personally fitted and produced on demand at the push of a button, without the constraints of conventional footwear manufacturing.

The products proved the future was possible. The platform makes it real. Zellerfeld is changing how footwear is created, sold and distributed, bringing the category into its next generation. Music had Spotify. Video had YouTube. Now footwear has Zellerfeld.

Explore and experience the next-generation at zellerfeld.com

About Zellerfeld
Zellerfeld is a technology company on a mission to digitize physical products, starting with footwear. Its full-stack platform connects digital product creation, custom fit and distributed 3D-printed production, turning shoes from digital files into physical products without moulds, stitching, glue or traditional assembly. Zellerfeld has proven the model across sport, fashion, design and culture: products designed digitally, fitted personally and made on demand. The company operates the world’s most advanced 3D-printing production facilities across Austin, Texas, and Hamburg, Germany.

View original content to download multimedia:https://www.prnewswire.com/news-releases/zellerfeld-gives-footwear-its-spotify-moment-302830114.html

SOURCE Zellerfeld

Continue Reading

Trending